éºäŒæ§ã®ç ããšãšãã«çãã
æ©çºæ§ã®éºäŒæ§çŸæ£ã®äžã€ãçè髿§çèçž®çïŒSBMAïŒãæäººæä»¥éã«çºçããæ£è ãã¡ãšãã®åšã§ããä¿å è ãã¡ã圌ã»åœŒå¥³ãã¯ããªã¹ã¯ããã©ã®ããã«æå³ã¥ããå®¶æãåšãã®äººã³ãšãšåãåãã人çã®éžæãããŠããã®ãã
Â
SBMAæ£è ã¯ã人çã®éäžã§ãæ£è ã«ãªããSBMAä¿å è ããŸãã人çã®éäžã§ãä¿å è ã«ãªã£ããå ããŠãããã¯éºäŒæ§ã®ç ãã§ããã£ãã圌ã»åœŒå¥³ãã¡ã¯ã人çã®éäžã§æ£è ãããã¯ä¿å è ã«ãªãããã以éãã©ã®ãããªçµéšãããŠããã®ã§ãããããéºäŒæ§ã®ç ããšãšãã«çããããããã¯éºäŒåŠçãªã¹ã¯ãšãšãã«çãããšã¯ãã©ã®ãããªçµéšãªã®ã ããããSBMAæ£è ãä¿å è ã®èªããæãããã«ãæ¬æžã§ã¯ãã®åãã«å¿ããªããã圌ã»åœŒå¥³ããSBMAãšãšãã«çããçµéšãæãåºããŠããããæ¬æããã®åŒçšã
Â
Â
âèè 玹ä»
æšç¢å¹žåïŒãã ããããïŒ
æ±äº¬å€§åŠå»ç§åŠç ç©¶æéå±ããã²ãã è§£æã»ã³ã¿ãŒå ¬å ±æ¿çç ç©¶åé婿ã
2019幎3ææ³æ¿å€§åŠå€§åŠé¢ç€ŸäŒåŠç ç©¶ç§åå£«åŸæèª²çšåäœååŸéåŠã
å士ïŒç€ŸäŒåŠïŒãå°éã¯ç€ŸäŒåŠã
äž»ãªèäœã«ããã軜床ããšãããæ£è ã®å°é£æ§ââçè髿§çèçž®çã«ããèº«äœæ©èœã®è¡°ãã®æåã«çç®ããŠããä¿å¥å»ç瀟äŒåŠè«éã32(2): 59?68, 2022ïŒãèªç¥çã®çºçåäºæž¬ã»äºé²ã®ELSIãšç ç©¶å«çããçè·ç ç©¶ã57(5): 459?465, 2024ïŒâAttitudes of patients with IVF/ICSI toward human embryo in vitro culture beyond 14 days,â Regenerative Therapy, 26: 831?836, 2024ïŒå ±èïŒãªã©ã
Â
Product Information
Product Information
Shipping & Returns
Shipping & Returns
éºäŒæ§ã®ç ããšãšãã«çãã
éºäŒæ§ã®ç ããšãšãã«çãã
æ©çºæ§ã®éºäŒæ§çŸæ£ã®äžã€ãçè髿§çèçž®çïŒSBMAïŒãæäººæä»¥éã«çºçããæ£è ãã¡ãšãã®åšã§ããä¿å è ãã¡ã圌ã»åœŒå¥³ãã¯ããªã¹ã¯ããã©ã®ããã«æå³ã¥ããå®¶æãåšãã®äººã³ãšãšåãåãã人çã®éžæãããŠããã®ãã
Â
SBMAæ£è ã¯ã人çã®éäžã§ãæ£è ã«ãªããSBMAä¿å è ããŸãã人çã®éäžã§ãä¿å è ã«ãªã£ããå ããŠãããã¯éºäŒæ§ã®ç ãã§ããã£ãã圌ã»åœŒå¥³ãã¡ã¯ã人çã®éäžã§æ£è ãããã¯ä¿å è ã«ãªãããã以éãã©ã®ãããªçµéšãããŠããã®ã§ãããããéºäŒæ§ã®ç ããšãšãã«çããããããã¯éºäŒåŠçãªã¹ã¯ãšãšãã«çãããšã¯ãã©ã®ãããªçµéšãªã®ã ããããSBMAæ£è ãä¿å è ã®èªããæãããã«ãæ¬æžã§ã¯ãã®åãã«å¿ããªããã圌ã»åœŒå¥³ããSBMAãšãšãã«çããçµéšãæãåºããŠããããæ¬æããã®åŒçšã
Â
Â
âèè 玹ä»
æšç¢å¹žåïŒãã ããããïŒ
æ±äº¬å€§åŠå»ç§åŠç ç©¶æéå±ããã²ãã è§£æã»ã³ã¿ãŒå ¬å ±æ¿çç ç©¶åé婿ã
2019幎3ææ³æ¿å€§åŠå€§åŠé¢ç€ŸäŒåŠç ç©¶ç§åå£«åŸæèª²çšåäœååŸéåŠã
å士ïŒç€ŸäŒåŠïŒãå°éã¯ç€ŸäŒåŠã
äž»ãªèäœã«ããã軜床ããšãããæ£è ã®å°é£æ§ââçè髿§çèçž®çã«ããèº«äœæ©èœã®è¡°ãã®æåã«çç®ããŠããä¿å¥å»ç瀟äŒåŠè«éã32(2): 59?68, 2022ïŒãèªç¥çã®çºçåäºæž¬ã»äºé²ã®ELSIãšç ç©¶å«çããçè·ç ç©¶ã57(5): 459?465, 2024ïŒâAttitudes of patients with IVF/ICSI toward human embryo in vitro culture beyond 14 days,â Regenerative Therapy, 26: 831?836, 2024ïŒå ±èïŒãªã©ã
Â
Product Information
Product Information
Shipping & Returns
Shipping & Returns
Description
æ©çºæ§ã®éºäŒæ§çŸæ£ã®äžã€ãçè髿§çèçž®çïŒSBMAïŒãæäººæä»¥éã«çºçããæ£è ãã¡ãšãã®åšã§ããä¿å è ãã¡ã圌ã»åœŒå¥³ãã¯ããªã¹ã¯ããã©ã®ããã«æå³ã¥ããå®¶æãåšãã®äººã³ãšãšåãåãã人çã®éžæãããŠããã®ãã
Â
SBMAæ£è ã¯ã人çã®éäžã§ãæ£è ã«ãªããSBMAä¿å è ããŸãã人çã®éäžã§ãä¿å è ã«ãªã£ããå ããŠãããã¯éºäŒæ§ã®ç ãã§ããã£ãã圌ã»åœŒå¥³ãã¡ã¯ã人çã®éäžã§æ£è ãããã¯ä¿å è ã«ãªãããã以éãã©ã®ãããªçµéšãããŠããã®ã§ãããããéºäŒæ§ã®ç ããšãšãã«çããããããã¯éºäŒåŠçãªã¹ã¯ãšãšãã«çãããšã¯ãã©ã®ãããªçµéšãªã®ã ããããSBMAæ£è ãä¿å è ã®èªããæãããã«ãæ¬æžã§ã¯ãã®åãã«å¿ããªããã圌ã»åœŒå¥³ããSBMAãšãšãã«çããçµéšãæãåºããŠããããæ¬æããã®åŒçšã
Â
Â
âèè 玹ä»
æšç¢å¹žåïŒãã ããããïŒ
æ±äº¬å€§åŠå»ç§åŠç ç©¶æéå±ããã²ãã è§£æã»ã³ã¿ãŒå ¬å ±æ¿çç ç©¶åé婿ã
2019幎3ææ³æ¿å€§åŠå€§åŠé¢ç€ŸäŒåŠç ç©¶ç§åå£«åŸæèª²çšåäœååŸéåŠã
å士ïŒç€ŸäŒåŠïŒãå°éã¯ç€ŸäŒåŠã
äž»ãªèäœã«ããã軜床ããšãããæ£è ã®å°é£æ§ââçè髿§çèçž®çã«ããèº«äœæ©èœã®è¡°ãã®æåã«çç®ããŠããä¿å¥å»ç瀟äŒåŠè«éã32(2): 59?68, 2022ïŒãèªç¥çã®çºçåäºæž¬ã»äºé²ã®ELSIãšç ç©¶å«çããçè·ç ç©¶ã57(5): 459?465, 2024ïŒâAttitudes of patients with IVF/ICSI toward human embryo in vitro culture beyond 14 days,â Regenerative Therapy, 26: 831?836, 2024ïŒå ±èïŒãªã©ã
Â